Zanosar (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Zanosar drug offered from Teva Parenteral Medicines, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
NON-PROPRIETARY NAME: | streptozocin |
SUBSTANCE NAME: | STREPTOZOCIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-12-03 |
END MARKETING DATE: | 0000-00-00 |
Zanosar HUMAN PRESCRIPTION DRUG Details:
Item Description | Zanosar from Teva Parenteral Medicines, Inc. |
LABELER NAME: | Teva Parenteral Medicines, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2003-12-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0703-4636_3ea01059-8c39-431c-a1c4-c03315b083e1 |
PRODUCT NDC: | 0703-4636 |
APPLICATION NUMBER: | NDA050577 |
Other STREPTOZOCIN Pharmaceutical Manufacturers / Labelers: